Aviva
ROIV icon

Aviva’s Roivant Sciences ROIV Stock Holding History

Aviva’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.93M Buy
+244,158
New +$8.85M 0.01% 543

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Aviva's ROIV Position: Q3 2026 in Review

Aviva opened a new position in Roivant Sciences (ROIV) in Q3 2026: 244,158 shares worth $8.93M. The stake represents 0.01% of the portfolio and ranks #543 among its holdings.

395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Aviva held 244,158 shares of Roivant Sciences worth $8.93M as of Q3 2026.
  • Roivant Sciences was a new Aviva position in Q3 2026.
  • Roivant Sciences made up 0.01% of Aviva's portfolio in Q3 2026, its #543 holding.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Aviva's 13F filing for Q3 2026, filed 12 Nov 2026.